Shkreli In The House: More Biopharma Cringing
This article was originally published in Scrip
House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) on Jan. 22 threatened to bring criminal charges of contempt against Martin Shkreli, rejecting excuses from his lawyer Baruch Weiss, of Arnold & Porter LLP, that the former CEO of Turing Pharmaceuticals Inc. may be unable to comply with a subpoena compelling him to appear before the congressional panel on Jan. 26.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.